HGF and pancreatic neoplasm: In the present study, we assessed the anti-neoplastic activity of targeting cMET with INC280 in pancreatic cancer models and found substantial in vitro inhibition of HGF-induced cancer cell motility and –signaling, as well as reversal of resistance-mediating properties.